StreetInsider.com Unusual 11 Mid-Day Movers 03/27/2007

Electronic Clearing House (Nasdaq: ECHO) 37% LOWER; Has mutually agreed with Intuit Inc. (Nasdaq: INTU) to terminate the merger agreement entered into by the companies on December 14, 2006.

Cimatron Limited (NASDAQ: CIMT) 31% HIGHER; Announced today the opening of two new offices in China. The new offices in Fujian and Wuhan will join the existing offices in Beijing, Chengdu, Guangzhou, Shanghai, and Wuxi, supporting the growing customer base and accelerating demand for Cimatron's products in China.

Nuvelo Inc. (Nasdaq: NUVO) 27.5% HIGHER; Company has been granted two separate fast track designations by the FDA for its product candidate, rNAPc2.

BioCryst Pharmaceuticals (Nasdaq: BCRX) 16.3% LOWER; Phase IIb Trial in T-ALL Voluntarily Placed on Hold by BioCryst Due to Stability Issue with the Intravenous Formulation of Fodosine.

FuelCell Energy (Nasdaq: FCEL) 16.4% HIGHER; Announced that the Connecticut Clean Energy Fund (CCEF) has screened and selected six energy projects, incorporating 68 megawatts (MW) of the company's fuel cell products.

CV Therapeutics, Inc. (Nasdaq: CVTX) 14.7% HIGHER; Stock bounces back after falling on Deutsche Bank's downgrade yesterday. Also, the company is to report finding on Ranexa, it's angina medication, today at the American College of Cardiology conference.

Technical Olympic USA Inc. (NYSE: TOA) 14% LOWER; Stock down following Lennar's (NYSE: LEN) earnings report. Residential Construction industry/sector down 2.55% today.

GameStop Corp. (NYSE: GME) 11.4% HIGHER; Reports Q4 EPS of $0.81, versus the consensus of $0.80. Revenues came in at $2.3 billion versus the consensus of $2.12 billion. Sees Q1 EPS of $0.15-$0.16, versus the consensus of $0.13. Sees Q1 comp sales up 12%-14%. Sees FY EPS of $1.37-$1.40, versus the consensus of $1.34. Sees FY comp sales up 14%-16%. Sees 2008 and 2009 EPS growth of at least 25%-year.

Regeneron Pharmaceuticals (Nasdaq: REGN) 11% HIGHER; Regeneron and Bayer HealthCare AG (NYSE: BAY) announced positive preliminary data from a pre-planned interim analysis of a Phase 2 randomized study of their VEGF Trap-Eye in patients with the neovascular form of age-related macular degeneration (wet AMD).

Osiris Therapeutics (Nasdaq: OSIR) 9.25% LOWER; Stock giving some back today after popping on yesterday's release regarding the clinical trial evaluating PROVACEL.

Martha Stewart Living Omnimedia (NYSE: MSO) 4.3% HIGHER; Bear Stearns upgrades Martha Stewart from Underperform to Peer Perform. Also, KB Home (NYSE: KBH) and Martha Stewart announced a home development collaboration in Los Angeles county.

You May Also Be Interested In

• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• Warner Bros Discovery to launch data platform for better ad-targeting
• Traders Push Back Timing Of First Fed Rate Cut To December - Bloomberg